The Jackson Laboratory for Genomic Medicine opened its doors
On Oct. 7, 2014, The Jackson Laboratory opened a state-of-the-art genomics research center on the campus of the…
On Oct. 7, 2014, The Jackson Laboratory opened a state-of-the-art genomics research center on the campus of the…
On Sept. 28, 2012, the Connecticut Challenge Survivorship Clinic opened at Yale Cancer Center providing — the first…
On Jul. 31, 2012, the Connecticut Development Authority (CDA) was merged into Connecticut Innovations (CI) which was created…
In 2012, Smilow Cancer Hospital and Yale Cancer Center opened 8 Smilow Cancer Care Centers in Connecticut. Today,…
In 2011, Precipio was founded in New Haven, Connecticut to build a platform designed to eradicate the problem…
On Oct. 26, 2009, the Smilow Cancer Hospital opened for patient care with María Rosa Menocal, a Yale…
On Jun. 23, 2009, the U.S. Department of Health and Human Services (HHS) announced advanced development contract for…
In 2007, West Campus, located on 136 acres 7 miles west of downtown New Haven, was acquired. West…
On Oct. 10, 2006, Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for…
On Aug. 31, 2022, Yale New Haven Hospital (YNHH) broke ground on the $838 million, 505,000 square foot…
On Mar. 11, 2004, The Kavli Foundation announced a $7.5 million award to establish the Kavli Institute of…
On Feb. 25, 2002, GlaxoSmithKline announced that the company would no longer manufacture or distribute its Lyme disease…
On Dec. 21, 1998, the Lyme Disease Vaccine (Recombinant OspA), (LYMErix by SmithKline Beecham) was licensed for use…
In 1998, Yale Cancer Center researchers discovered the gene, Survivin, which is linked to the detection of some…
In 1995, Bristol-Myers’ Wallingford, Connecticut facility was named the Richard L. Gelb Center for Pharmaceutical Research and Development…
In 1992, the U.S. Centers for Disease Control and Prevention (CDC) launched a national surveillance for tick-borne Lyme…
In 1990, Connecticut United for Research Excellence Inc. (CURE) was founded. CURE was a statewide coalition of educational…
In 1989, Connecticut Innovations (CI), created by the Connecticut Legislature, provides strategic capital and operational support to advanced…
In 1988, oncologists from Yale Cancer Center performed the first bone marrow transplant in Connecticut at the Yale-New…
On Jul. 9, 1981, Frank Ruddle from Yale University, Frank Costantini and Elizabeth Lacy from Oxford, and Ralph…
In 1979, Joan Steitz discovered snRNPs, RNA-protein complexes in the cell’s nucleus that perform a crucial step in…
In 1981, researcher William Burgdorfer, Ph.D., at the National Institute for Allergy and Infectious Diseases (NIAID) Rocky Mountain…
In 1974, Yale Cancer Center received a National Cancer Institute (NCI) designated comprehensive cancer center status, the only…
In 1965, Yale established the first university-based department of clinical pharmacology and chemotherapy in the United States (the…
In 1963, Yale New Haven Hospital (then Grace-New Haven) installed the first linear accelerator in Connecticut for cancer…
In 1959, William Prusoff of Yale University discovered idoxuridine, the first effective antiviral that fights herpes by interfering…
In 1953, Yale established the first pharmacology department in the U.S. to focus on cancer chemotherapy and cancer…
In 1949, the first artificial heart pump was developed at Yale by William H. Sewell and William W….
In 1942, the first intravenous chemotherapy treatment of a cancer patient was performed at Yale.
In 1942, Yale cancer research began when the first use of a cancer drug was administered to a…